Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia-Challenges, strengths, and opportunities in a global health emergency.
Aged
Betacoronavirus
Blood Gas Analysis
COVID-19
Computer Simulation
Coronavirus Infections
/ complications
Female
Humans
Italy
Machine Learning
Male
Middle Aged
Models, Statistical
Pandemics
Pneumonia, Viral
/ complications
Prospective Studies
Respiration, Artificial
Respiratory Insufficiency
/ diagnosis
SARS-CoV-2
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
06
2020
accepted:
02
09
2020
entrez:
12
11
2020
pubmed:
13
11
2020
medline:
24
11
2020
Statut:
epublish
Résumé
The aim of this study was to estimate a 48 hour prediction of moderate to severe respiratory failure, requiring mechanical ventilation, in hospitalized patients with COVID-19 pneumonia. This was an observational prospective study that comprised consecutive patients with COVID-19 pneumonia admitted to hospital from 21 February to 6 April 2020. The patients' medical history, demographic, epidemiologic and clinical data were collected in an electronic patient chart. The dataset was used to train predictive models using an established machine learning framework leveraging a hybrid approach where clinical expertise is applied alongside a data-driven analysis. The study outcome was the onset of moderate to severe respiratory failure defined as PaO2/FiO2 ratio <150 mmHg in at least one of two consecutive arterial blood gas analyses in the following 48 hours. Shapley Additive exPlanations values were used to quantify the positive or negative impact of each variable included in each model on the predicted outcome. A total of 198 patients contributed to generate 1068 usable observations which allowed to build 3 predictive models based respectively on 31-variables signs and symptoms, 39-variables laboratory biomarkers and 91-variables as a composition of the two. A fourth "boosted mixed model" included 20 variables was selected from the model 3, achieved the best predictive performance (AUC = 0.84) without worsening the FN rate. Its clinical performance was applied in a narrative case report as an example. This study developed a machine model with 84% prediction accuracy, which is able to assist clinicians in decision making process and contribute to develop new analytics to improve care at high technology readiness levels.
Identifiants
pubmed: 33180787
doi: 10.1371/journal.pone.0239172
pii: PONE-D-20-16454
pmc: PMC7660476
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0239172Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2020 May 7;382(19):1787-1799
pubmed: 32187464
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089
pubmed: 32396163
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Euro Surveill. 2020 Mar;25(11):
pubmed: 32209164
J Transl Med. 2020 May 20;18(1):206
pubmed: 32434518
BMJ Open. 2018 Jan 11;8(1):e018880
pubmed: 29330175
BMJ. 2020 Apr 7;369:m1328
pubmed: 32265220
JAMA. 2018 Dec 4;320(21):2199-2200
pubmed: 30398550
Anesthesiology. 2020 Jun;132(6):1317-1332
pubmed: 32195705
Radiology. 2020 Aug;296(2):E86-E96
pubmed: 32301647
Nat Med. 2020 Jul;26(7):1017-1032
pubmed: 32651579
Cytometry A. 2020 Mar;97(3):215-216
pubmed: 32142596
JAMA Netw Open. 2020 Jan 3;3(1):e1918962
pubmed: 31922560
Eur Heart J Cardiovasc Imaging. 2020 Apr 1;21(4):437-445
pubmed: 31230076
PLoS Med. 2018 Nov 30;15(11):e1002707
pubmed: 30500815
Metabolism. 2017 Apr;69S:S36-S40
pubmed: 28126242